About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

As a service to the BioPharma community in these unprecedented times, USAIC is offering Free Registration for its annual summit.
Registration is closed. Thanks for your overwhelming response. See you at 2021 summit- June 22. Marriott Cambridge, Massachusetts, USA
17th Annual BioPharma & Healthcare Summit, Wednesday, May 3, 2023 - Virtual Meeting
Registration is closed
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!

Chair and Master of Ceremonies (Emcee) - Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
16th annual BioPharma & Healthcare Summit

Virtual Summit
Date: Friday, June 24, 2022
Time: 8 AM EST to 3:30 PM EST (Eastern Standard Time)

*Speaker and Timings subject to change
Time Topic
8:00 AM - 8:10 AM Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
8:10 AM - 8:55 AM Moving Closer to Cure for More Cancer Patients

Dr. Christine Ward, Vice President, Head of Oncology and Cell Therapy, Takeda Pharmaceuticals
Dr. Eric Rubin, Senior Vice President, Therapeutic Area Head Oncology, Early Development, Merck Research Labs
Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
Dr. Sam Waksal, Chairman and Chief Executive Officer, Equilibre Biopharmaceuticals
Dr. Todd Golub, Director and Founding Core Member, Broad Institute of MIT & Harvard

Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
8:55 AM - 9:00 AM Polling + Break
9:00 AM - 9:40 AM Fireside Chat

Alex Gorsky, Executive Chairman, Johnson & Johnson

Christopher Viehbacher, Founding Partner, Gurnet Point Capital
9:40 AM - 9:45 AM Polling + Break
9:45 AM - 10:30 AM

Clinical Trials Landscape in India

Dr. Cynthia Verst, President, Design & Delivery Innovation for Research and Development Solutions, IQVIA
Dr. Kush Parmar, Managing Partner, 5AM Ventures
Dr. Naresh Trehan, Chairman, Medanta
Peter Ronco, Head of Global Development, Janssen Research and Development, Johnson & Johnson
Dr. Vinod Paul, Member, National Institution for Transforming India, the NITI Aayog

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals

10:30 AM - 10:35 AM Polling + Break
10:35 AM - 11:20 AM Digital & Data Science Panel

Daphne Zohar, Founder & Chief Executive Officer, PureTech Health
Dr. Karen Akinsanya, President of Research and Development, Therapeutics, Schrodinger
Dr. Regina Barzilay, Professor of AI and Health, Massachusetts Institute of Technology
Sastry Chilukuri, Co-Chief Executive Officer, Medidata
Dr. Vipin Gopal, Chief Data & Analytics Officer, Eli Lilly

Chris Benko, Co-Founder and Chief Executive Officer, Koneksa Health
11:20 AM - 11:25 AM Polling + Break
11:25 AM - 12:10 PM Pandemics: Where does the world go from here

Dr. Larry Tabak, Acting Director, National Institutes of Health (NIH)
Dr. John Mascola, Chief Scientific Officer, ModeX Therapeutics
Dr. Julie Gerberding, Chief Executive Officer, Foundation for the NIH (FNIH)
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon

Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University
12:10 PM - 12:20 PM Polling + Break
12:20 PM - 1:05 PM Industry & Investment Outlook Panel

Christopher Viehbacher, Founding Partner, Gurnet Point Capital
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

Jennifer Fox, Chief Financial Officer, Nuvation Bio
1:05 PM - 1:10 PM Polling + Break
1:10 PM - 1:55 PM Rethinking Rare: Resolutions for reinvention in a genomic age

Dr. Alfred Sandrock, Chief Executive Officer, Voyager Therapeutics
Charlene Son Rigby, Chief Executive Officer, RARE-X
Paula Soteropoulos, Chairman of the Board, Ensoma
Dr. Philip Larsen, Global Head of Research, Bayer Pharma
Max Bronstein, Assistant Director for Health Innovation, White House Office of Science & Technology Policy

Dr. Timothy Yu, Associate Professor in Pediatrics, Harvard Medical School

1:55 PM - 2:00 PM Polling + Break
2:00 PM - 2:50 PM Research and Development Strategies & Trends Panel

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. John Reed, Global Head of Research and Development, Sanofi
Dr. Mathai Mammen, Executive Vice President, Pharmaceuticals, Research and Development, Johnson & Johnson

Dr. Martin Mackay, Co-Founder, Rallybio
2:50 PM - 3:20 PM Closing Remarks and Wrap Up

Dr. Andrew Plump, President of Research and Development, Takeda Pharmaceuticals
Advisory Board Members and Speakers
Pharmasia News BioCentury







Roivant Science





© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us